TY - JOUR
T1 - Erratum
T2 - Focal segmental glomerulosclerosis(Clin J Am Soc Nephrol (2017),12,502-517, 10.2215/CJN.05960616)
AU - Rosenberg, Avi Z.
AU - Kopp, Jeffrey B.
N1 - Publisher Copyright:
© 2018 by the American Society of Nephrology.
PY - 2018/12/7
Y1 - 2018/12/7
N2 - Due to author error, a correction has been issued for the above referenced article. The following sentence inaccurately spells out suPAR. The text should have read “soluble urokinase-type plasminogen activator receptor” instead of “serum urine–type plasminogen activator receptor”. The authors regret any confusion this may have caused to readers. “Current candidates for the recurrent FSGS factor, reviewed recently (44), include cardiotrophin like cytokine factor 1 (45), apoA1b (an isoform of ApoA1) (46), anti-CD40 antibody (47), and serum urine–type plasminogen activator receptor (suPAR) (48).”.
AB - Due to author error, a correction has been issued for the above referenced article. The following sentence inaccurately spells out suPAR. The text should have read “soluble urokinase-type plasminogen activator receptor” instead of “serum urine–type plasminogen activator receptor”. The authors regret any confusion this may have caused to readers. “Current candidates for the recurrent FSGS factor, reviewed recently (44), include cardiotrophin like cytokine factor 1 (45), apoA1b (an isoform of ApoA1) (46), anti-CD40 antibody (47), and serum urine–type plasminogen activator receptor (suPAR) (48).”.
UR - http://www.scopus.com/inward/record.url?scp=85060960402&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85060960402&partnerID=8YFLogxK
U2 - 10.2215/CJN.12071018
DO - 10.2215/CJN.12071018
M3 - Comment/debate
C2 - 30413403
AN - SCOPUS:85060960402
SN - 1555-9041
VL - 13
SP - 1889
JO - Clinical Journal of the American Society of Nephrology
JF - Clinical Journal of the American Society of Nephrology
IS - 12
ER -